as soon as the vaccine is authorized by the fda. so the first step in the process, that's when we will begin to ship pending the cdcs -- cdc's decision. we'll ship about 15 million doses out nationwide in those next few days with millions more going out each and every week to make sure that we're matching the doses with where they're most needed, where there's the greatest demand. so to put the first week's allocation in perspective, the 15 million going out all in that first week, it took 12 weeks back at the end of 2020 and into 2021, it took 12 weeks to get enough supply out into the field to vaccinate half of the eligible adult population. so we will be doing all of that upfront with millions of more doses each week. so we're in very, very good shape here. so the bottom line is there will be plenty of supply and we look forward to parents having the opportunity to vaccinate their kids pending the fda and cdc decision-making. dr. fauci on jeremy's second question. dr. fauci: yeah, jeremy, you bring up a good point. you know, mont

at the same time, obviously defer to the science and the the fda. and i think we learned that lesson, as i said earlier from the prior administration where the decision was made by the fda and cdc and the operations weren't ready. and that meant that adults at the time were not able to receive their vaccines as efficiently, equitably as possible. and this will enable us to be ready for kids. on vaccinations for kids and requirements, first i'll just start by that's really about schools and vaccinations and practicing, as dr. walensky said, proven health measures including masking, distancing, and ventilation is the best way to keep scho have been around for decad at the state and local level. we know that in general requirements work and we support states and school districts taking actions to ensure that vaccinated. but again, those decisions should be made at the state and local level. one more question, kevin. dr. murthy: [crosstalk] can i actually add one thing to your last comment? mr. zients: please. dr. murthy: so cheryl, to your question, i'

but the fda, we have just heard, are going to meet, fda advisors going to meet end of next month to talk about that very promising antiviral pill that could be rolled out to treat covid-19. jake. >> all right. nick watt in los angeles. thanks. >>> as the fda panel holds these critical votes this week we are learning that the white house is vetting a former fda chief to lead the agency once again. cnn chief white house correspondent kaitlin. the fda has been acting under an acting commissioner. she has been highly criticized for her role in the fda in the opioid epidemic. what do we know about this possible replacement? >> the she ran the drug division when many critics say opioids were liberally approved by the agency. that's why she has fallen out of contention for this job. the white house is vetting every candidates, including rob kay live. he is a card yol squlis who, as you noted, previously certained as the commission ergs of the fda under obama for a short period of time and so now the white house is closing on him potentially as their next pick for the fda commissioner. this has

. >>> new data on booster shots on the eve of critical fda advisory meeting. are people who got the johnson & johnson vaccine better off getting a pfizer or moderna booster? we'll tell you what a new study found. >>> a horrific bow and arrow attack. multiple people killed what we're learning about it >>> our nbc news exclusive on havana syndrome. three of the original victims of the mystery illness speaking out for the first time, the symptoms they suffered and were they targeted by deliberate attacks. >>> and the new warning by the fda on how much salt you are eating what you need to know. >>> this is nbc "nightly news" with lester holt >>> good evening the white house tonight responding to the growing supply chain disruption that has left cargo ships waiting at sea to unload and consumers and small retailers burdened with shortages and delivery delays for all kinds of products president biden today hailing a deal with the massive port of los angeles to begin operating 24/7 the second west coast port to go around the clock it is part of a major push to reliev

fda's approach is purposefully conservative. fda assess vaccines within six months post. each slide shows the model and input of where we call scenario. two general assumptions were made. first vaccine protection is six months post second dose and vaccine efficacy remains constant. the second is covid cases, hospitalization, icu state and death are stable over the period. for use of covid data. and that's with a september 11th. with covid efficacy, a prior approved september 11th for instngs of hospitalization. and historical for icu death. we assume vaccine efficacy 70% against hospitalizations. on c-span vaccine, they started. and monitors the vaccine recipients four years old. for both predelta and delta period. to estimate the risks, we have 80 plus. that is the health data, a part of fda. two to 15 years data because the data to 5 to 11 years age is not available. so, late on icu stage, vaccine relates myocarditis cases were up. they were starting to be associated with vaccine, related cases. the majority of the myo cases are in a short period of time. each space sce

new fda guidelines on how much sodium we consume. proposing changes for food mnufacturers, restaurants, cafeteri cafeterias, and food trucks. (jackie) i've made progress with my mental health. so when i started having unintentional body movements called tardive dyskinesia... i ignored them. but when the twitching and jerking in my face and hands affected my day to day... i finally had to say, 'it's not ok.' it was time to talk to my doctor about austedo. she said that austedo helps reduce td movements in adults... while i continue with most of my mental health medications. (vo) austedo can cause depression, suicidal thoughts, or actions in patients with huntington's disease. pay close attention to and call your doctor if you become depressed, have sudden changes in mood, behaviors, feelings, or have suicidal thoughts. common side effects include inflammation of the nose and throat, insomnia and sleepiness. don't take austedo if you have liver problems, are taking reserpine, tetrabenazine, or valbenazine. austedo may cause irregular o

the fda analysise. provides adequate analysis of the benefit and risk of overdose 10-microgram vaccination of young children with 90.seven efficacy. the fda presentation notes there have been more than 44 million covid-19 cases eight.seven between five through 11 -year-olds hospitalized children with chronic lung disease obesity and neurologic disorders were a higher risk the benefit risk ratio in the comparative scenario analysis presented in table 14 is my primary figure with the icu admissions versus to the myocarditis and with thoseio scenarios that is most realistic and then august 2021 and scenario number four with 90 percent efficacy against september 11 no currents approximately four / three ratio of icu admissions first vaccinated children versus 58 for the placebo group this benefit ratio supports vaccination for five through 11 -year-old and other policy considerations including suppressing virus reproduction and various development protecting the rest of the population with the immunosuppres

the fda advisory panel will review it on friday. meanwhile, the white house is also telling governors to start preparing to vaccinate children as young as five by early next month. in anticipation of clearance of pfizer's vaccine for that age group in the coming weeks. >> by vaccinating kids, fewer breakthrough cases, fewer cases in schools and less transmission at home. >> reporter: new data shows last week covid cases in the u.s. dropped 12% from the previous week. hospitalizations down 11%. still -- >> despite the recent decrease in cases, most communities across the country are still experiencing substantial to high levels of community transmission and we're certainly not in a place where cases are in a control area. >> reporter: but there may be some light at the end of the tunnel. starting in november, the biden administration will lift restrictions at the u.s. borders with canada and mexico for fully vaccinated travelers. for 19 months, all non-essential travelers including family members and tourists could not cross, hurting

we review vaccines and related product applications at the fda. i will be presenting a review of the evidence of safety of the pfizer biotech vaccine in children 5-11 years of age submitted under the emergency authorizationca amendment. i'd like to start off by acknowledging the many contributions of my colleagues -- cover the design submitted to support the eu a, the supported efficacy data included in the overall summary. [inaudible] the eu a for the two dose primary series of the pfizer covid-19 vaccine 10 micrograms administered three weeks apart. the vaccine composition is based on a protein encoded by [inaudible] it is formulated in -- the fda has debated this previously and included the pfizer covid-19 vaccine to individuals 12 years of age or older with and without certain compromised immune systems. each dose is 30 micrograms of mrna. in august of this year the pfizer covid-19 vaccine known as 162 b2 was approved under this application. as mentioned, with an indication to prevent covid-19 and individuals 16 years of age or older. the appr

fda has just authorized booster shots of the johnson & johnson covid vaccines for millions of americans hours after the biden admini children miguel almaguer now with the latest. >> reporter: authorized by the fda late today, booster shots for adults fully vaccinated with moderna and johnson & johnson could be days away the stage now set for the cdc's review after the fda also approved mixing and matching boosters >> done! >> reporter: it comes as the white house unveiled its massive plan to begin vaccinating 28 million children between the ages of 5 and 11 who could qualify for their first shot of pfizer's vaccine as soon as early november >> so the main idea of this -- >> reporter: the logistical roll-out using trusted sites like schools and community centers to ensure families have easy access to the free vaccines. >> why is vaccinating this age group so important?

the fda is questioning the evidence johnson&johnson provided in its application for booster shots. scientists say there may be a benefit two months after the initial dose the agency noted the data is limited, saying a ke fda didn'te enough time to independently review much of the raw data from the trial. ahead of an advisory panel this friday it's not clear whether these concerns would be enough to delay emergency use authorization. >> we have the vaccine supply and we'll be ready to hit the ground rung as soon as any additional boosters are authorized. >> reporter: and now, a new highly anticipated study by the nih shows mixing and matching v vaccine boosters, and j&j are better off than the moderna boosters meanwhile, the white house is also telling governors to start preparing to vaccinate children as young as five in anticipation of the clearance for that age group in the coming weeks. >> by vaccinating fewer break through cases, fewer cases in school and less transition at home. >> new data shows last week covid cases dropped 12% from the previous week. still. >> despite the r

the fda and the cdc. the first committee to meet is the fda's vaccine and related biological products advisory committee. it holds a public meeting were scientific experts weigh in on the data and discuss key scientific questions. the fda synthesizes the committee's proceedings and then makes an official decision that can be implemented by our health care system. a similar process has been conducted by the cdc. the cdc advisory committee on immunization practices holds a public meeting were scientific experts weigh in on the data and answer key questions. and following that meeting, the cdc takes their input into account and makes a clinical recommendation for health care providers. to summarize, advice is offered and then the fda makes a decision. and this cdc makes a decision off of the other meeting's advice. helpful guidance is provided to the fda and cdc as the agencies themselves make their ultimate decision. this process is not new. it has been around long before covid-19. during the pandemic, this

heat, also a former fda official. what do we know right now about this upcoming fda decision and how soon might folks start getting these mixed doses? >> reporter: we know about the process. there is reporting we could learn about the fda authorizing boosters as early as tomorrow night. once that happens, then it goes to the cdc for their recommendation. millions of americans could be eligible for a booster shot by the end of this week. we've heard from the white house covid task force. they have said as soon as the green light is issues, they say they have the vaccines ready and will be ready to roll them out. >> it sounds like they are planning to approve this mixing and matching of vaccines. help us understand. we know, for example, there's been a lot of pressure from state officials who wanted flexibility in the types of doses they can give people for the booster shot. how do they come to making a plan here? >> for the u.s. fda they have to be constrained to the science. can they suggest booster shots that mix and

following the fda and cdc decision last week pfizer, j&j and motrin are now available for tens of millions of eligible americans. we workk with governors, state and local health departments, pharmacies, doctory health centers and long-term care facility to be ready for this moment. thanks to planning and preparation we are off to a veryng strong start. in just the first five days, one.5 million americans got the enhance protection of modern or j&j booster shots. and 15 million americans now have received an additional dose of phaser or internet or j&j. so the booster program is off to a strong start. we are working with states and pharmacies and other partners to efficiently and equitably get boosters to tens of millions of eligible americans. we are also planning for the rollout. 28million young americans to become eligible should the fda authorize and cdc recommend ages five through 11. states placed initial orders of vaccines for kids and without authorization millions of doses should be shipped immediately to tens of thousands of pediatricians, family doctors, children's hospitals, com

by -- this is an advisory panel that fda has. fda has to say, okay, yeah, we're going to take the advice. then it goes to cdc's advisory panel, and cdc's director to get the final word on it. that takes, you know, several days. but think of less than a week. so i think by november we're going to be able to start vaccinating 5 to 11-year-olds, and this is just with pfizer. >> thank you, dr. rutherford. any booster shots available for giants fans, by the way, before you go? >> the superstar booster? i don't know. i'll leave that to you guys. >> we appreciate your time. have a good weekend. >>> well, the bay area's biggest county about to implement some major water cutbacks. this will impact more than 1 million people. the south bay's shrinking reservoirs is one reason the san jose water company is asking for a mandatory 15% cutback in water use. they'll base that 15% on how much water you used in 2019. if you don't cut back enough, here's the bottom line here. you're going to have to pay a penalty. $7 for every 748 gallons you use.

assuming that the fda panel recommend this and the fda and cdc follow suit and those are assumptions, but assuming that happens, what do parents need to know when they decide whether or not to vaccinate their kids? >> well, first of all, we're going to hear from the advisory committee on immunization practices, from the centers for disease control and then dr. walensky has to sign off on it. possibly as early as november 2nd, november 3rd we could have that option. the answer is, jake, you know, this -- the delta variant has taught us that kids can get very sick and lots of kids can get very sick with the delta variant. we've had 8300 hospital admissions of kids between the ages of 5 to 11, about half of them have had this very serious multisystem inflammatory syndrome of children. we've had at least 100 deaths in the 5 to 11 age category. and we have about 14% of the kids, according to some estimates, having long covid symptoms lasting more than 15 months. so we have to get away from this false impression that kids do really well with covid-19. some do, but many do not. and so i thin

that key fda panel now voting on the johnson & johnson booster today. unanimously voting yes on a second shot. when to get this shot, and this time a major difference when it comes to who should get it. and the question asked today in that room -- should the johnson & johnson shot have been two shots to begin with? we'll break it all down for you. what you need to know tonight. >>> also tonight, news on former president bill clinton. in the hospital for several days in california. what we now know about his condition. hillary clinton visiting him in the hospital, and matt gutman is ther

it could clear the fda and cdc by the first week of november. when it does, the biden administration says there will be millions of doses ready to go. here's abc's erielle reshef. >> reporter: just a day before an fda panel is set to review and rule on pfizer's vaccine for 5 to 11-year-olds, promising news on moderna's vaccine in younger children. the company reporting a strong immune response in kids 6 to 11. at just half the adult dose, two shots given 28 days apart produced one and a half times the antibodies seen in young adults. and like pfizer, moderna says its vaccine was safe in the younger group with mild side effects like headache, sore arm, fever and fatigue. >> pediatricians who care for these kids want to find a solution. it's a miracle we potentially have one. >> reporter: 28 million children could be eligible for a pfizer shot as early as thursday, november 4th, after a green light from the fda and cdc. the pfizer vaccine was found to be 91% effective in 5 to 11 year olds. pediatrician amanda dropic enrolled all four of her childr

pfizer has asked the fda to approve its vaccine for kids ages 5 through 11. the dosage would be much lower and the first shot could go out in just weeks. laura podesta has more from new york. laura, good morning. >> reporter: good morning, anne marie. yes, the aim is for kids to be able to start booking appointments by thanksgiving. this is great news for school districts overwhelmed by cases and great news for the biden administration, which has repeatedly said vaccines are the way to end the pandemic. 11. pfizer has asked the fda for an emergency use authorization for that age group. pfizer's pediatric covid vaccine is a low-dose version of its regular shot. it contains just a third of the amount given to adults and teenagers, but in tests, it offered similarly strong protection against the virus. >> you want to maximize protection with the fewest amount of side effects. >> reporter: experts welcome the announcement, saying while most children can tolerate a covid infection, not all do. >> sometimes we're not able to predict well who will suffer severe cons

but let me just say, i'm running the fda, i'm very experienced, i have worked at the fda for many decades. i know what needs to be done. we're getting done what needs to get done. and, you know, of course i can't comment on any nomination or anything like that. >> but are you confident that the fda is running as it should, even in the absence of a permanently-named commissioner? >> well, i believe that certainly some of the staff feels some uncertainty. however, i believe that the leadership of the agency is functioning at a very high level. >> nbc's senior white house correspondent shannon pettypiece is in washington for us. shannon, i'm glad you're here joining us. i know, so our viewers know, you and i have been talking in the run-up to this interview and after about this story. there's reporting out there that dr. woodcock is not going to be the one getting the job, i know you're looking at that, as well as when the administration is up against a deadline to basically figure something else out. you asked the press secretary about this yesterday. >> hallie, i wish i had a better answer

le preguntamos quÉ significa la aprobaciÓnde la fda para el gobierno de joe biden. javier: paulina, es otro paso importante, ojalÁ lo logremos pronto. el fda tiene que dar la palabra, pero es algo mÁsque nos va dar la protecciÓn que necesitamos ya entrando el invierno porque sabemos que el invierno es el perÍodo cuando la enfermedad pega mÁs fuerte. paulina: se van a cumplir los retos, secretario, en la teorÍa de tiempos de vacunaciÓn? estamos cerca de diciembre. javier: todos tenemos la obligaciÓn y responsabilidad de cuidarnos. el presidente tiene la mayor responsabilidad de hacer posible esta protecciÓn. lo que hace la fda es muy importante y lo que hace nuestro residente para hacer accesibles las vacunas es muy importante para toda la familia y toda la comunidad. paulina: su mensaje en especÍfico para la comunidad hispana en este tema cuÁl serÍa? javier: el mensaje principal tenÍa que ser gracias porque hace meses empece a decir de la comunidad que no nos estamos abonando, todos se estÁn acuÑando menos nosotros. ahora nuestra comunidad se estÁ va

big day as we're watching the fda. we appreciate your reporting on this. >>> coming up, could the virginia governor's race give us clues about what to expect from next year's midterms. we have a special look at this race, and the big warning that we're hearing from a big name democrat. and how new abortion restrictions are affecting texas women. i spoke to two women who left the state for the procedure about their decision. >> i would have had to wait, like, a month for my first appointment, and by that time just with the new law, i would have been out of the time limit to get the abortion. [ kimberly ] before clearchoice, my dental health was so bad i would be in a lot of pain. i was unable to eat. it was very hard. kimberly came to clearchoice with a bunch of missing teeth, struggling with pain, with dental disease. clearchoice dental implants solved her dental issues. [ kimberly ] i feel so much better. i feel energized to go outside and play with my daughter. i can ate anything. like, i don't have to worry. clearch

next the fda has to meet. then the cdc has to meet. first, let's take a look at what this panel said. this panel said that they think people. >>> get moderna doses and half the dose of the original shot. half the dose because moderna says that's plenty and then they can save on vaccine and send it out to other parts of the world, and you have to be eligible, meaning you have to have been more than six months or at least six months past your second moderna shot. so if you just got your moderna shots last month, this is not for you. and in addition to being at least six months out, you have to be either at least 65 years old or have certain medical conditions or live or work in a risky place. for example, a health care worker at risk of getting covid or perhaps someone who lives in a nursing home. so what happens now is the fda listens to its advisors and makes a decision. we have every reason to think that the fda will agree with the advisors. then the cdc is scheduled to take a look thursday of next week. we also have every reason to t

the fda is now weighing in, and that story is next. tonight, i'll be eating lobster ravioli with shaved truffles. yes! you look amazing! no, you look amazing! thank you! thank you! thank you! thank you! thank you! thank you! haha, you're welcome. i'll shoot you an estimate as soon as i get back to the office. hey, i can help you do that right now. high thryv! thryv? yep. i'm the all-in-one management software built for small business. high thryv! ow. get a free demo at thryv.com. (birds chirping) ♪ (upbeat music) ♪ (phone beep) ♪ ♪ ♪ ♪ ♪ ♪ ♪ (music quieter) ♪ (phone clicks) ♪ ♪ alberto and i don't fit into those other family plans. that's why we love visible. they do things differently. yeah, it's wireless with unlimited data and if you join a group it's as low as $25/mo. all powered by verizon. 5g included. woo! just get together and save! we look goooood! what's everyone's handle? visible. unlimited data, as low as $25/mo all-in. powered by verizon, 5g included. wireless that gets better with friends. constipa

that key fda panel late today saying yes. and the states of emergency right now. tonight, this nor'easter, another round, new york to new england. wind gusts reaching 75 miles per hour. >>> first, that pfizer child vaccine. the vote near unanimous. 17 in favor, one abstaining. and the new data tonight. pfizer saying the vaccine is 91% effective for children against symptomatic infections. this vaccine for kids 5 to 11, children will receive two shots, each shot one-third of the adult dose. we know many parents still have questions tonight, so dr. jha is standing by to help answer them. >>> also, that powerful nor'easter still childrening. tonight, more heavy rain, flash flooding. and now, our weather team says one of the real concerns going into the night, dangerous winds. gusts up to 75 miles per hour. and the new storms at the end of the week. rob marciano tracking it all. >>> the major new headline from that movie set disaster. for the first time tonight, images of actor alec baldwin and the crew on that set in that church where the deadly shooting occurred. an

the fda is meeting to discuss approving vaccines for kids as young as 5. what parents in the bay area are saying about the possibility of the shot going into their children's arms. >>> good tuesday morning. thanks for joining us for our midday newscast. i'm cierra johnson. >> i'm kris sanchez. the final step in approving covid vaccinations or authorizing them for the younger schoolchildren could be just days away. the fda advisory committee is meeting as we speak to consider authorizing the pfizer vaccine for kids 5 to 11 years old and we could have a decision by next week. >> nbc bay area's thom jensen is in mill valley where parents say they're eager to get their kids vaccinated. >> good morning. that's not surprising to hear in this community that's highly educated and already of the eligible folks here, 90% vaccination rate here in marin county. and this fda committee is the final decision-making panel in this process. members heard from experts on what they are finding in clinical trials, adverse reaction and efficacy rates. pfizer is also reporting a

it is welcomed news and have to have fda look at the data. that's a different committee than mine and we would welcome it if it's safe and effective. >> is the goal with booster to prevent infection or severe disease and hospitalization? doesn't the original vaccine hold up relatively well for a long period of time against severe disease >> correct you are on the money to the extent they remain effective after the primary series they're most effective to keep you out of the hospital and the icu and from being killed by the deadly virus that is the good news. with time we see some breakthrough of moderate disease and mild disease and you could say it's mild/moderate we don't want people to have that second of all people with that can spread it to others so in order of operations the priority is to keep people out of the hospital but to reduce the chance to be infected is wonderful because that can get us to herd immunity. the israeli data presented yesterday they use the pfizer product suggestioed with the bos ores i believe to 12 they start t

it wasn't right to tweet at fda. that wasn't a good way to reform the fda. >> this is a good point. >> this diagnosis wasn't completely wrong. there was reason to be frustrated with the performance of the agency. >> frustrated with the performance of the experts and the scientists. >> and the function of the agency and the information the white house was getting. >> that's not going to help either. >> now that they have a harder time exerting control over the agency like they did with the booster but it looked like they were now interfeing with the scientific work. i don't think either approach is optimal. >> don't you have something in an interview or a book that a couple of people in cdc have now left because they are being pushed around by the politicals? is that what you think is happening? >> i don't know the exact reason. it was senior officials. i don't know the exact reason they left. i think there were mull approximate reasons why they left. i think the cdc director is attempting to reform the agency. it's v

the fda says the authorization does not mean that products are safe or fda approved. >>> older adults without heart disease should not take daily aspirin to prevent a first heart attack or stroke. that is the word from a top medical panel. they say bleeding risks for adults 60 and over outweigh any benefit from aspirin. a daily dose could be appropriate for those in their 40s, if there is no bleeding risk. as always, the advice, consult your doctor. >>> still ahead at 5:30, a look at new technology that could make your next flight a lot smoother. we will tell you where it's already being tested out. >>> a record number of workers are quitting their jobs. a look at the numbers and businesses being impacted. >>> this quiet corner of san francisco, a dead-end street no less, is suddenly seeing a princess cruises was born right here in california. for over 55 years, we've been helping californians make the most of their precious vacation time. and right about now, we could all use a real vacation. so forget the road trips and rentals and sail with princess right from san francisco to the

tomorrow the fda advisory panel weighs boosters for the one-shot j&j vaccine. they'll also debate whether to allow mixing and matching vaccines and boosters. a new study from the n.i.h. found that practice is safe and effective. ian cull, nbc bay area news. >>> once the moderna booster gets the final go ahead from the fda and cdc, nearly 70 million americans who got that shot will be able to get another dose. but it will only be half of the original dose, 50 micrograms. in comparison, people getting the pfizer booster will get the same dosage as the original shot and that's 30 micrograms. >>> when it comes time for you to get your booster shot, you'll have to add it to your vaccine record. our consumer investigator chris chmura shows you how even if you lost your original vaccine card. just head to nbcbayarea.com/howto. >>> the los gatos mom accused of hosting the drufrpger sex parties for 14 and 15-year-olds will be extradited to the bay area next week. shannon o'connor also known as shannon south bay with sheriff deputies, she will stand before a santa clara

shep >> the fda clearing mix-and-match boosters just now. any surprises to report? >> yeah, the fda is being really broad how it's allowing people to switch vaccine type boosters if they want to. there may be an expectation to stay with the same kind but allowing switches when necessary. so the guidance for j&j folks is two months out from their first shot, they can get another j&j, pfizer or half dose of moderna folks who got moderna or pfizer that are in the eligibility groups can get a booster of any of those six months out. the cdc advisers are meeting tomorrow to discuss all of this, which could provide more clarity to folks wondering which one they should get. after that, eligible folks should be able to get their booster shots as soon as friday. shep >> i hope so thank you, meg. >>> covid case cans are now declining across every region of the entire world, except europe. the world health organization reports the united kingdom and russia are the hardest hit today the russian president vladimir putin ordered workers across the country to stay home for a solid

today, the fda authorized the pfizer covered vaccine for children's aged 5-11, two steps away from going into young arms. recent polls show only one third of parents plan to. many more have questions. here to answer questions, special correspondent dr. patel. dr. patel in the house. dr. patel: delivering a little halloween treat right now for everyone out there. kristen: review on the abc 7 zoom, where you could get prizes if your child is a cutie pie and has a great costume? did you miss it? dr. patel: i did miss that. she doesn't have a costume on right now. she's just giggling. she wants everyone to see her skull and bones these. -- booties. kristen: she would have cleaned up you guys are quite the pair. i award you the best 3:00 p.m. costume of 2021. dr. patel: thanks, kristen. i'll take that little kiss now. she's gone. less cute, but now going to talk about covid vaccines for children. dr. patel: you know how it goes. i know our viewers know what to do. tell me which one of these is not true. is it a, the pfizer vaccine for children is a lower dose primarily to increase distributio

let's get to the fda advisers this week. and part of their discussion involving openly questioning whether authorizing boosters for too many people, potentially giving the idea that vaccines are not protecting especially if you have a booster. and especially when you take public messaging in consideration, how should the biden administration approach boosters? >> well, first of all, thanks for having me. with defendantconsistent messagf the problems we've had through the pandemic is we've gotten mixed messages. but this is complicated because we have three different vaccines. each have different properties. the j&j, for example, most people have known you had to have a second vaccine. and frankly, only two vaccines have ever been one dose. yellow fever and the flu vaccine. so two doses, i think, is going to be required for the j&j vaccine. so, i'm not surprised by that. boosters sort of finish the job. and the administration will explain very carefully who absolutely should get boosters immediately. and eventually, i think e

>> answer any questions the community has with those answers involving the fda and sponsors. >> first of all thank you for a thorough presentation to let me ask this question. were you to include the data presented where the doctor found 40 percent five through 11 -year-olds were zero positive with urinalysis correct me if i'm wrong assuming that all five through 11 -year-olds were susceptible to illness? she showed that many weren't or are arguably not through serious illness or parent can reasonably say my child is zero positive they are protected against serious illness there is still not much known and refused to wait so how do you think that would change urinalysis and what would you say to that parent? >> . >> and with the cdc and there is no vaccine. so we account for everyone to consider the credible that in this group that have immunity butw then i don't know because it depends if somebody tests positive what is the protection. so those individuals and then went that propensity of the vaccine and then to have 45 percent from the benefit. so we don't know if somebody has a pos

and what fda is doing is it's actually catching up to policy, alisyn. catching up to practice. so, the policy is catching up to practice. clinicians already are working with people across the u.s. to make sure that they get their boosters, including if they had moderna initially or if they had j&j, so over the next couple days, we'll clean this all up, harmonize all of these various recommendations and have a single consistent policy. >> speaking of harmonizing, the last time the fda went through this process of approving a booster for pfizer, there were resignations and disagreements and reversals. what are you expecting as they look through the steps of moderna and j&j, because the request for moderna is narrower here for specific populations to get the booster. >> correct. and it's consistent with what eventually happened with pfizer. it's because there isn't a whole lot of data suggesting that moderna loses a lot of its efficacy, and so they actually have even gone with half a dose. for j&j, my expectation is that while j&j may be approved for a second dose, the fda also wi

we don't know a time line for when the fda might do their review. we know from monoclonal antibodies, another treatment, when they apply for emergency use authorization, it took about six weeks for the fda to do the review for that. that gives you a bit of a ballpark idea. boris? >> some good news and a lot to look out for. elizabeth cohen, thank you. joining us is dr. paul offit, a member of the fda vaccine advisory committee and the director of the vaccine education center at the children's hospital of philadelphia. always a pleasure having you on and getting your insight. let's start with merck seeking emergency use authorization for that oral antiviral drug. how does it work? who is is it designed for? how much of a game changer do you think it will be? >> it prevents the virus from reproducing itself, and that's certainly an advantage. it's about 50% effective at preventing hospitalization. remember, the vaccine is virtually 99% effective at preventing hospitalization, so an ounce of prevention is worth a pound of cure. you'd much rather preven

once the fda gives the authorization, pfizer will submit for full fda approval. vaccine still doesn't have full approval for kids 12 to 15. a key mile marker for california's school vaccine mandate. >> we intend to do that once the fda has fully approved the vaccine. >> reporter: is a governor explained, kids will be required to be vaccinated until the vaccine is full approval for kids 12 to 15, so when can your kids get it, and when might they have to get it? let's break it down. the vaccine already has full fda approval for kids 16 and older, but only has emergency years authorization for kids 12 to 15. pfizer is expected to request full approval for that end by the end of the year, and the fda is expected to move quickly, so the school vaccine mandate for kids 12 and older will take effect until january at the earliest, but it could be as late as july area as for the 5 to 11-year-olds, the fda said it hopes to meet by the end of the month to consider the emergency use authorization, but could be months before pfizer is even ready to submit for full fda approva

as you know the fda is dr. murthy said has scheduled meetings for late this month and early next month so we have been in frequent conversations as i mentioned with all of the providers to get them prepared the same way we got folks prepared for a successful launch of the pfizer boost booster campaign. wen. best governors to take stes to enroll providers such as pediatricians who rely heavily on pediatricians and family doctors in the vaccination program so they can bring -- they can begin providing vaccinations right away. we have state without region education campaigns to focus on parents and families and the communities and we have communicated and will continue to communicate as it has been with all of her efforts and that means ensuring we have areas of high social vulnerability and rural a areas. if it's authorized by the fda and the cdc we will be ready and we have the supply and i want to emphasize the different supply, but does for kids is a different host than adults who will have a different supply

en la fda estamos comprometidos a tomar decisiones respaldadas en la ciencia y en las que la gente pueda confiar, decÍa mÁs temprano el director del centro de evaluaciÓn biolÓgica e investigaciones de la agencia. la fda anunciÓ que antes de que los niÑos comiencen a recibir la vacuna los cdc y los expertos analizarÁn quiÉnes deben ser vacunados. el doctor shapiro es pediatra y padre de familia. >> los niÑos estÁn en las escuelas y han habido mucho mÁs confiados. por ello el hecho de proteger a nuestros niÑos es sumamente bÁsico e importante. locutor: los niÑos sÓlo recibirÁn una tercera parte de la dosis que recibe un adulto. >> se midiÓ cuÁl es la mejor dosis para los niÑos. guillermo: hoy el vicepresidente de pfizer dijo: estamos buscando mÁs y mÁs buenos capÍtulos que nos deben al final del libro, y a una posiciÓn en la que podamos decir que el covid—19 quedÓ atrÁs. la decisiÓn de la fda permitirÁ que pediatras puedan tener la vacuna en sus oficinas listas para iniciar la vacunaciÓn tan pronto como lo digan los cdc. patricia: uno de los mÉdicos que entre

the fda didn't make any direct authorization. but if you have been vaccinated with johnson & johnson and getting one of those mrna vaccines, the pfizer or moderna could increase your antibodies. >> thanks very much. i spoke to dr. anthony fauci about the vaccination plan for younger kids, and i wonder whether acting before the vaccinations are approved is somewhat presumptuous. >> i don't think it is presumptuous because we have made it clear that whatever happens will be dependent on the regulatory decision of the fda and the recommendations on the part of the cdc. we want to have the vaccine already distributed in pediatric offices, in pharmacies, in children's hospitals and in community centers. if we did not do that preparation, there would be a time lag in getting that vaccine to the children. >> let's talk about the resistance, defiance, whatever you want to call it to the current vaccines by adults what do you anticipate when it comes to giving shots to children, where people will lean? >> well, i hope they will be enthusi

we're talking about full fda approval. if and when it does have full fda approval for children, would it be added to the list of vaccinations that are corrurren required in public schools? >> we'll see. first i'm waiting for the emergency use authorization. it will tell parents now is a good time to get your younger kids vaccinated. let's start with that. we'll see when we get the full approval what we have to do next year i think. >> as you know, a lot happening and yet not happening at the same time in washington these days. the infrastructure bill that's essentially stuck right now, as we look at i believe connecticut was set to receive some $5 billion over the next five years. what does it mean for your state? what's at stake here if this bill doesn't pass? >> yeah. come on, president trump knew how important infrastructure was, couldn't get it over the finish line. let's let the congress get it over the finish line. that first bill means the world to a state like connecticut which has pretty old infrastructure. i coul

the cdc and fda will weigh in on those boosters this week, and then all eyes will turn to the fda panel reviewing pfizer's vaccine for kids 5 to 11. what is the white house saying to do right now? >> reporter: they're telling states to preorder doses for 5 to 11-year-olds in hopes of a seamless rollout that could start in about 2 1/2 weeks. the fda already reviewing pfizer's vaccine for kids. the cdc will meet the first week of november. linsey? >> janai, thank you. >>> earlier today, former president bill clinton walked out of a california hospital six days after being admitted for an infection. the 75-year-old and his wife, hillary clinton, thanking doctors and staff at uc irvine medical center. his condition is not uncommon for men his age. and there are warning signs. marcus moore is there. >> reporter: six days after he arrived at this southern california hospital fighting an infection, former president bill clinton walked out on his own with a show of gratitude. the doctors and nurses who treated him lining up outside as clinton left with his wife, former secretary of state hillar

the fda has fully approved the vaccine. >> reporter: is a governor explained, kids will be required to be vaccinated until the vaccine is full approval for kids 12 to 15, so when can your kids get it, and when might they have to get it? let's break it down. the vaccine already has full fda approval for kids 16 and older, but only has emergency years authorization for kids 12 to 15. pfizer is expected to request full approval for that end by the end of the year, and the fda is expected to move quickly, so the school vaccine mandate for kids 12 and older will take effect until january at the earliest, but it could be as late as july area as for the 5 to 11-year-olds, the fda said it hopes to meet by the end of the month to consider the emergency use authorization, but could be months before pfizer is even ready to submit for full fda approval for the younger kids. >> currently, state law allows for exemptions for vaccines, meaning parents could choose not to get it, but there has been a lot of talk about amending the law to prevent that. >> joining us live with some perspective is dr. ge

they typically sign off rather quickly after the fda. it also comes as the white house now rolls out its plan to get millions of doses of the pfizer vaccine for children 5 to 11 the moment regulators give it the green light. children will get two shots, three weeks apart and each of those shots will be about a third of the adult dose. the vaccine for children once approved will be available at doctor's offices, pharmacies and potentially even at schools. and tonight, also news, americans eligible for boosters now, that group could soon be widened to include everyone 40 and older. here's whit johnson. >> reporter: tonight, the fda officially authorizing booster shots for moderna and johnson & johnson and allowing americans to mix and match any of the three vaccines as a booster. the moderna booster for the same population as pfizer after six months for people 65 and older and those at high risk due to health or where they work. j&j boosters after two months for anyone over 18. and that green light for people who want to boost with a diffe